Vγ9Vδ2 T Cells Concurrently Kill Cancer Cells and Cross-Present Tumor Antigens

The human Vγ9Vδ2 T cell is a unique cell type that holds great potential in immunotherapy of cancer. In particular, the therapeutic potential of this cell type in adoptive cell therapy (ACT) has gained interest. In this regard optimization of in vitro expansion methods and functional characterizatio...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Immunol
Autori principali: Holmen Olofsson, Gitte, Idorn, Manja, Carnaz Simões, Ana Micaela, Aehnlich, Pia, Skadborg, Signe Koggersbøl, Noessner, Elfriede, Debets, Reno, Moser, Bernhard, Met, Özcan, thor Straten, Per
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2021
Soggetti:
Immunology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8208807/
https://ncbi.nlm.nih.gov/pubmed/34149689
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.645131
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi